Funder: European Commission
Due Dates: October 9, 2025 (Stage 1) | April 29, 2026 (Stage 2)
Funding Amounts: Total budget: €8,825,000 (indicative for this topic); project duration typically 3–5 years
Summary: Supports collaborative research to accelerate the development, standardization, and clinical integration of beta-cell therapy for Type 1 Diabetes in Europe.
Key Information: Legal entities from the UK and Canada are not eligible for funding under this call.